Development of an LC–MS/MS Method for Quantifying Occidiofungin in Rabbit Plasma
Journal of Mass Spectrometry · 2025
DOI: 10.1002/jms.5121 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Mass Spectrometry, 2025. Verfasst von Andrew Cothrell und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biology, Texas A&M University, College Station, Texas, USA. Hauptthemen laut MEDLINE: Tandem Mass Spectrometry, Antifungal Agents. Die Arbeit nennt 18 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: NIAID NIH HHS, Texas A&M University, National Institute of Allergy and Infectious Diseases.
Abstract (Originalsprache)
Fungal infections are caused by opportunistic pathogens that can be life threatening and have been growing in prevalence. Many clinically relevant pathogens have resistance to or are developing resistance to the commonly used antifungal treatments. Occidiofungin (OCF) is a unique cyclic lipoglycopeptide with a novel structure that includes noncanonical amino acid in its covalent structure. It exhibits broad spectrum antifungal activity and has activity against drug resistant Candida species. Occidiofungin is a fungicidal compound that has a novel mechanism of action in which it disrupts higher order actin structures. Currently, occidiofungin is being developed for use in treating vulvovaginal candidiasis (VVC) and recurrent vulvovaginal candidiasis (RVVC). This study describes the development and application of a bioanalytical method for the quantification of occidiofungin in rabbit plasma. Method development was performed to quantify occidiofungin in rabbit plasma after intravaginal administration of a hydrogel containing occidiofungin. The method was validated with a linear range of 30–15 000 ng/mL in rabbit plasma. Precision, accuracy, calibration curve linearity, and stability of drug in plasma were established in quality controls. Extract stability, matrix effects, and recovery of drug in the extract were also determined. This study supported a repeat dose toxicity study in rabbits to determine occidiofungin pharmacokinetics and toxicokinetics. The pharmacokinetic and toxicokinetic primarily showed plasma concentrations of occidiofungin below the limit of quantification (BLOQ), suggesting that OCF‐B does not readily cross the vaginal epithelial membrane.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Biology, Texas A&M University, College Station, Texas, USA.
- Antimicrobial Division, Sano Chemicals Inc., Bryan, Texas, USA.
ORCID-Profile: Leif Smith
Förderung
- NIAID NIH HHS
- Texas A&M University
- National Institute of Allergy and Infectious Diseases
- Texas A and M University
Zitieren
APA
Cothrell, A., Orugunty, R. S., & Smith, L. (2025). Development of an LC–MS/MS Method for Quantifying Occidiofungin in Rabbit Plasma. Journal of Mass Spectrometry. https://doi.org/10.1002/jms.5121
Vancouver
Cothrell A, Orugunty RS, Smith L. Development of an LC–MS/MS Method for Quantifying Occidiofungin in Rabbit Plasma. Journal of Mass Spectrometry. 2025. doi:10.1002/jms.5121
BibTeX
@article{Cothrell2025,
author = {Cothrell, Andrew and Orugunty, Ravi S and Smith, Leif},
title = {Development of an LC–MS/MS Method for Quantifying Occidiofungin in Rabbit Plasma},
journal = {Journal of Mass Spectrometry},
year = {2025},
doi = {10.1002/jms.5121}
}
EUVIMED